Literature DB >> 31870818

Postoperative Symptomatic Cerebral Infarction in Pediatric Moyamoya Disease: Risk Factors and Clinical Outcome.

Jung Won Choi1, Sangjoon Chong2, Ji Hoon Phi3, Ji Yeoun Lee3, Hee-Soo Kim4, Jong Hee Chae5, Joongyub Lee6, Seung-Ki Kim7.   

Abstract

BACKGROUND: Indirect bypass surgery is used to improve the hemodynamic status of pediatric patients with moyamoya disease (MMD). Symptomatic cerebral infarction during the early postoperative period may be the most frustrating complication. This study was conducted to investigate the factors associated with early postoperative symptomatic cerebral infarction.
METHODS: Between January 2000 and February 2014, we performed 1241 indirect bypass surgeries in 659 pediatric MMD patients. Symptomatic infarction during the early postoperative period was diagnosed in 63 operations in 61 patients.
RESULTS: The overall incidence of symptomatic cerebral infarction after indirect bypass surgery was 5.1%. The median age of the patients with postoperative infarction was 6 years (mean, 6.4 years; range, 1-15 years). The performance of 2 craniotomies in single operation was associated with a higher rate of cerebral infarction. Moreover, the incidence was higher in young patients (age <6 years) compared with older patients. In a matched analysis, an immediate postoperative hemoglobin level >13 g/dL was associated with decreased risk of infarction (odds ratio, 0.144; P = 0.003). Mutation of the methylenetetrahydrofolate reductase (MTHFR) gene occurred in a relatively high proportion of our infarction cohort.
CONCLUSIONS: Postoperative symptomatic infarctions can occur despite a unified surgical method and formulaic perioperative management protocol. Patient-centered factors, such as young age, genetic background of MTHFR, and certain medical conditions, including hyperthyroidism, renovascular hypertension, and hemolytic uremic syndrome, as well as management-related factors, including 2 craniotomies and low immediate postoperative hemoglobin level, could be risk factors for early postoperative symptomatic cerebral infarction.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bypass; Complication; Indirect; Infarction; Moyamoya

Mesh:

Year:  2019        PMID: 31870818     DOI: 10.1016/j.wneu.2019.12.072

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Masaki Sumitomo; Sho Okamoto; Kota Matsui; Ryo Emoto; Toshihiko Wakabayashi; Shigeyuki Matsui; Atsushi Natsume
Journal:  Neurosurg Rev       Date:  2021-01-08       Impact factor: 3.042

2.  Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.

Authors:  Xiang Guo; Xuexia Yuan; Lingyun Gao; Yueqin Chen; Hao Yu; Weijian Chen; Yunjun Yang; Zhen Chong; Zhanguo Sun; Feng Jin; Deguo Liu
Journal:  Eur Radiol       Date:  2021-05-06       Impact factor: 5.315

3.  Classification Algorithm-Based fMRI Images for Evaluating the Effect of Yishen Tiaodu Acupuncture on the Recovery Period of Cerebral Infarction.

Authors:  Zhuo Feng; Miaomiao Hu; Wei Yuan; Xiaojun Zhao; Jiazhi Zeng; Kaibin Zhou
Journal:  Comput Intell Neurosci       Date:  2022-05-25

4.  Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.

Authors:  Masahito Katsuki; Miki Fujimura; Ryosuke Tashiro; Yasutake Tomata; Taketo Nishizawa; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2020-09-24       Impact factor: 3.042

5.  Successful Treatment of Recurrent Renal Artery Stenosis in a Patient with Moyamoya Disease by Aorto-Renal Bypass with Autogenous Vein Graft.

Authors:  Hyunmin Ko; Seung-Kee Min
Journal:  Vasc Specialist Int       Date:  2022-01-17

6.  The First 24 h Hemodynamic Management in NICU after Revascularization Surgery in Moyamoya Disease.

Authors:  Jie Song; Yu Lei; Long Chen; Chao Gao; Wei Ni; Xing Wu; Gang Wu; Ying Mao; Jin Hu; Yuxiang Gu
Journal:  Behav Neurol       Date:  2021-10-12       Impact factor: 3.342

Review 7.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.